News
The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.
The band can be worn during the day and night, allowing patients to track blood pressure patterns across a 24-hour cycle.
FirstLight and RadiantLight evaluated the safety and efficacy of oveporexton for the treatment of narcolepsy with cataplexy in participants aged 16 to 70 years old.
Baxdrostat is an investigational highly selective, oral, small molecule designed to inhibit aldosterone synthase.
The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.
Even more concerning? The loss of data. The US funded most HIV tracking systems in Africa, and many have now stopped collecting patient and hospital records.
Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes ...
The USPSTF meets several times a year to review the latest science and decide which screenings, medications and other preventive services should be fully covered by insurance.
HealthDay News — For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild cognitive impairment (MCI), according to a study published ...
Introduction of immune checkpoint inhibitors linked to widening disparity for those with private insurance versus those without insurance.
However, childhood cancer survivors have lower risk for registered COVID-19 infection relative to comparators.
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results